Literature DB >> 23494325

Shenfu Injection suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure.

Si-Dao Zheng1, Hong-Jin Wu, Shao-Ping Yu, Jian-Xun Ren, Wei-Wei Duo, Zeng-Chun Ma, Yue Gao, Sheng-Qi Wang, Yu-Na Liu.   

Abstract

OBJECTIVE: To investigate the regulatory effects of Shenfu Injection (SFI, ) on hemodynamic parameters and serum proteins in rats with post-infarction chronic heart failure (CHF).
METHODS: Forty-five healthy Wistar rats were randomized into three groups: sham, heart failure (model) and SFI group. The CHF was induced by left coronary artery ligation. Seven days after the surgical operation, animals in the sham group and the model group received saline (6.2 mL/kg/d), while animals in the SFI group received SFI (6.2 mL/kg d) intraperitoneally. Four weeks later, cardiac hemodynamic parameters were measured via the carotid route. The expression of serum proteins was analyzed by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometer (MALDI-TOF MS).
RESULTS: Recording of hemodynamic parameters showed that left ventricular systolic pressure (LVSP), maximum rate of left ventricular pressure (+dp/dtmax) rise, and maximum rate of left ventricular pressure (-dp/dtmax) decrease, while the left ventricular end diastolic pressure (LVEDP) rose in the model group compared to those in the sham group (P <0.05). The results of the MALDI-TOF MS indicated that haptoglobin (HP), pentraxin 3 (PTX3) and alpha-1-antitrypsin were up-regulated, while serum albumin and 40S ribosomal protein were down-regulated in the model group (P <0.05). Compared with the model group, LVSP, +dp/dtmax and -dp/dtmax were higher, while LVEDP was lower in the SFI group (P<0.05). Expression levels of HP and PTX3 were lower than in the model group (P<0.05).
CONCLUSION: SFI could improve hemodynamic function and decrease inflammatory reactions in the pathophysiology of CHF. The serum proteins HP and PTX3 could be potential biomarkers for chronic ischemic heart failure, and they could also be the serum protein targets of SFI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494325     DOI: 10.1007/s11655-013-1440-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  41 in total

1.  [Efficacy of shenfu injection as adjuvant therapy in treating patients of ischemic cardiomyopathy with heart insufficiency].

Authors:  Xiao-Ying Luo; Feng-Ru Zhang; Ru-Min He
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2009-08

2.  Heart failure: pentraxin 3—a marker of diastolic dysfunction and HF?

Authors:  Bernhard M Kaess; Ramachandran S Vasan
Journal:  Nat Rev Cardiol       Date:  2011-05       Impact factor: 32.419

3.  Role of Shenfu Injection in rats with systemic inflammatory response syndrome.

Authors:  Jin Wang; Li-fen Qiao; Guang-tian Yang
Journal:  Chin J Integr Med       Date:  2008-06-21       Impact factor: 1.978

4.  Shen-Fu injection preconditioning inhibits myocardial ischemia-reperfusion injury in diabetic rats: activation of eNOS via the PI3K/Akt pathway.

Authors:  Yang Wu; Zhong-yuan Xia; Qing-tao Meng; Jie Zhu; Shaoqing Lei; Jinjin Xu; Juan Dou
Journal:  J Biomed Biotechnol       Date:  2010-11-29

Review 5.  Effects of exercise training on inflammatory markers in patients with heart failure.

Authors:  Josef Niebauer
Journal:  Heart Fail Rev       Date:  2008-02       Impact factor: 4.214

6.  Proteome analysis on an early transformed human bronchial epithelial cell line, BEP2D, after alpha-particle irradiation.

Authors:  Wantao Ying; Kaitai Zhang; Xiaohong Qian; Ling Xie; Jie Wang; Xiaoqiong Xiang; Yun Cai; Dechang Wu
Journal:  Proteomics       Date:  2003-01       Impact factor: 3.984

7.  [Cytokines mechanism of shenfu injection in treatment of cardiogenic shock in canine].

Authors:  Da-Zhi Ke; Qing-Wei Chen; Chun-Li Li; Gui-Qiong Li
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2007-11

8.  [Influence of shenfu injection on heart function and bone marrow stem cell mobilization in patients with chronic heart failure of coronary heart disease].

Authors:  Yuan-Hui Hu; Hua-Qin Wu; Xin Qi
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2009-04

Review 9.  In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.

Authors:  Ajay M Shah; Douglas L Mann
Journal:  Lancet       Date:  2011-08-20       Impact factor: 79.321

10.  Chinese medicine shenfu injection for heart failure: a systematic review and meta-analysis.

Authors:  Song Wen-Ting; Cheng Fa-Feng; Xu Li; Lin Cheng-Ren; Liu Jian-Xun
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-24       Impact factor: 2.629

View more
  3 in total

1.  The Association between Yang-Deficient Constitution and Clinical Outcome of Highly Active Antiretroviral Therapy on People Living with HIV.

Authors:  Yuwen Cen; Ross Ka-Kit Leung; Fuchun Zhang; Weidong Jia; Jiansheng Zhang; Xinghua Tan; Feilong Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-30       Impact factor: 2.629

2.  Pharmacodynamic Evaluation of Shenfu Injection in Rats With Ischemic Heart Failure and Its Effect on Small Molecules Using Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging.

Authors:  Hao Wu; Zhenfeng Dai; Xi Liu; Ming Lin; Zeyu Gao; Fang Tian; Xin Zhao; Yi Sun; Xiaoping Pu
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

3.  The protective effects of Shen-Fu injection on experimental acute pancreatitis in a rat model.

Authors:  Lei Huang; Jun Cao
Journal:  Oxid Med Cell Longev       Date:  2014-03-05       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.